Azithromycin Microspheres in Patients With Low Risk Community Acquired Pneumonia
Community-Acquired Pneumonia
About this trial
This is an interventional treatment trial for Community-Acquired Pneumonia
Eligibility Criteria
Inclusion Criteria: Male or female, 18 years age or older, for whom oral, outpatient therapy is indicated. Diagnosis of CAP as manifested by at least 3 or more of the following: cough, pleuritic chest pain, fever (temperature of >37.8 C to <40 C), auscultatory findings on pulmonary examination of rales and/or evidence of pulmonary consolidation, dyspnea, tachypnea, laboratory results of elevated total peripheral white blood count (WBC> 10,000/mm3 or greater than 15% immature neutrophils (bands) Exclusion Criteria: Known or suspected hypersensitivity or intolerance to azithromycin or other macrolides. Previously diagnosed disease(s) of immune function, including: subjects with baseline absolute neutrophil count < 1,000/mm3, HIV positive subjects with CD4 count < 200 cells/mm3, any immunoglobin or neutrophil disorder.
Sites / Locations
- Pfizer Investigational Site
- Pfizer Investigational Site
- Pfizer Investigational Site
- Pfizer Investigational Site
- Pfizer Investigational Site